Your browser doesn't support javascript.
loading
Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data
Roy Burstein; Bejamin M Althouse; Amanda Adler; Adam Akullian; Elizabeth Brandstetter; Shari Cho; Erin Chung; Anne Emmanuels; Kairsten Fay; Luis Gamboa; Peter Han; Kristen Huden; Misja Ilcisin; Mandy Izzo; Michael L Jackson; Ashley E Kim; Louise Kimball; Kirstein Lacombe; Jover Lee; Jennifer K Logue; Julia Rogers; Thomas R Sibley; Katrina Van Raay; Edward Wenger; Caitlin R Wolf; Michael Boeckh; Helen Chu; Jeff Duchin; Mark Reider; Jay Shendure; Lea M Starita; Cecile Viboud; Trevor Bedfor; Janet A Englund; Michael Famulare; - Seattle Flu Study and SCAN Investigators.
Afiliação
  • Roy Burstein; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA
  • Bejamin M Althouse; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA
  • Amanda Adler; Seattle Children's Research Institute, Seattle WA USA
  • Adam Akullian; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA
  • Elizabeth Brandstetter; Department of Medicine, University of Washington, Seattle WA USA
  • Shari Cho; Brotman Baty Institute for Precision Medicine, Seattle WA USA
  • Erin Chung; Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle
  • Anne Emmanuels; Department of Medicine, University of Washington, Seattle WA USA
  • Kairsten Fay; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA
  • Luis Gamboa; Brotman Baty Institute for Precision Medicine, Seattle WA USA
  • Peter Han; Brotman Baty Institute for Precision Medicine, Seattle WA USA
  • Kristen Huden; Department of Medicine, University of Washington, Seattle WA USA
  • Misja Ilcisin; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA
  • Mandy Izzo; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA
  • Michael L Jackson; Kaiser Permanente Washington Health Research Institute, Seattle WA USA
  • Ashley E Kim; Department of Medicine, University of Washington, Seattle WA USA
  • Louise Kimball; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA
  • Kirstein Lacombe; Seattle Children's Research Institute, Seattle WA USA
  • Jover Lee; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA
  • Jennifer K Logue; Department of Medicine, University of Washington, Seattle WA USA
  • Julia Rogers; Department of Medicine, University of Washington, Seattle WA USA
  • Thomas R Sibley; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA
  • Katrina Van Raay; Brotman Baty Institute for Precision Medicine, Seattle WA USA
  • Edward Wenger; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA
  • Caitlin R Wolf; Department of Medicine, University of Washington, Seattle WA USA
  • Michael Boeckh; Department of Medicine, University of Washington, Seattle WA USA; Brotman Baty Institute for Precision Medicine, Seattle WA USA; Vaccine and Infectious Disease
  • Helen Chu; Department of Medicine, University of Washington, Seattle WA USA
  • Jeff Duchin; Department of Medicine, University of Washington, Seattle WA USA; Public Health Seattle & King County, Seattle WA USA
  • Mark Reider; Brotman Baty Institute for Precision Medicine, Seattle WA USA
  • Jay Shendure; Brotman Baty Institute for Precision Medicine, Seattle WA USA; Department of Genome Sciences, University of Washington, Seattle WA USA; Howard Hughes Medical In
  • Lea M Starita; Brotman Baty Institute for Precision Medicine, Seattle WA USA; Department of Genome Sciences, University of Washington, Seattle WA USA
  • Cecile Viboud; Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.
  • Trevor Bedfor; Brotman Baty Institute for Precision Medicine, Seattle WA USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA;
  • Janet A Englund; Seattle Children's Research Institute, Seattle WA USA; Brotman Baty Institute for Precision Medicine, Seattle WA USA
  • Michael Famulare; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA
  • - Seattle Flu Study and SCAN Investigators;
Preprint em Inglês | medRxiv | ID: ppmedrxiv-22270474
ABSTRACT
BackgroundCo-circulating respiratory pathogens can interfere with or promote each other, leading to important effects on disease epidemiology. Estimating the magnitude of pathogen-pathogen interactions from clinical specimens is challenging because sampling from symptomatic individuals can create biased estimates. MethodsWe conducted an observational, cross-sectional study using samples collected by the Seattle Flu Study between 11 November 2018 and 20 August 2021. Samples that tested positive via RT-qPCR for at least one of 17 potential respiratory pathogens were included in this study. Semi-quantitative cycle threshold (Ct) values were used to measure pathogen load. Differences in pathogen load between monoinfected and coinfected samples were assessed using linear regression adjusting for age, season, and recruitment channel. Results21,686 samples were positive for at least one potential pathogen. Most prevalent were rhinovirus (33{middle dot}5%), Streptococcus pneumoniae (SPn, 29{middle dot}0%), SARS-CoV-2 (13.8%) and influenza A/H1N1 (9{middle dot}6%). 140 potential pathogen pairs were included for analysis, and 56 (40%) pairs yielded significant Ct differences (p < 0.01) between monoinfected and co-infected samples. We observed no virus-virus pairs showing evidence of significant facilitating interactions, and found significant viral load decrease among 37 of 108 (34%) assessed pairs. Samples positive with SPn and a virus were consistently associated with increased SPn load. ConclusionsViral load data can be used to overcome sampling bias in studies of pathogen-pathogen interactions. When applied to respiratory pathogens, we found evidence of viral-SPn facilitation and several examples of viral-viral interference. Multipathogen surveillance is a cost-efficient data collection approach, with added clinical and epidemiological informational value over single-pathogen testing, but requires careful analysis to mitigate selection bias.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
...